What role does VDR play in menopause?

The Vitamin D Receptor (VDR) is a nuclear receptor that mediates the effects of vitamin D. During menopause, estrogen decline accelerates bone resorption, increasing osteoporosis risk. VDR plays a key role in calcium absorption and bone metabolism. Certain VDR polymorphisms (e.g., FokI, BsmI, TaqI) have been associated with differences in bone mineral density and fracture risk. However, the evidence is largely based on association studies and mechanistic reasoning; robust human trials demonstrating that targeting VDR variants improves menopausal outcomes are lacking. A consumer DNA test reporting VDR variants should be interpreted with caution: it cannot replace clinical assessment of vitamin D status via serum 25(OH)D measurement. Supplementation decisions should be guided by blood levels, bone density scans, and overall health profile, not by genetics alone. Be wary of marketing claims that overstate the role of VDR in menopause. The receptor is relevant, but its genetic variation explains only a small fraction of the variability in bone health. Evidence level: mechanistic to moderate association.